Cardiac lesions induced by 5-fluorouracil in the rabbit

Human and Experimental Toxicology

Volumn 25, Issue 6, 2006, Pages 305-309

  Tsibiribi, P ^a   Bui Xuan, C ^a   Bui Xuan, B ^a   Lombard Bohas, C ^b   Duperret, S ^c   Belkhiria, M ^a   Tabib, A ^d   Maujean, G ^d   Descotes, J ^e   Timour, Q ^a,e  

^a UNIVERSITÉ LYON 1   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c CROIX ROUSSE HOSPITAL   (France)

^d Lyon Institute of Forensic Medicine   (France)

^e Poison Center   (France)

Author keywords

5 fluororacil; Apoptosis; Cardiotoxicity; Coronary spasm; Mechanism; Rabbit

Indexed keywords

CHLORBUTOL; FLUOROURACIL; KETAMINE; XYLAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; CORONARY ARTERY SPASM; ENDOTHELIUM CELL; EPICARDIUM; FEMALE; HEART INFARCTION; HEART INJURY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE NECROSIS; MALE; MICROSCOPY; MYOCARDITIS; NICK END LABELING; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CARDIOMYOPATHIES; CORONARY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; FLUOROURACIL; MALE; RABBITS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 33745985405     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327106ht628oa     Document Type: Article

References (22)

1. Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. Drug Saf 2000; 22: 263-302.
2. Longley DB, Harkin DP, Johnston PG. 5-Fluorouracil: mechanisms of action and clinical strategies. Nature Rev Cancer 2003; 3: 330-38.
3. Anand AJ. Fluorouracil cardiotoxicity. Ann Pharmacother 1994; 28: 374-78.
4. Becker K, Erckenbrecht JF, Häussinger D, Frieling T. Cardiotoxicity of the antiproliferative compound fluorouracil. Drugs 1999; 57: 475-84.
5. Collins C, Weiden PL. Cardiotoxicity of 5-fluorouracil. Cancer Treat Rep 1987; 71: 733-36.
6. El Attar AF, Skeel RT, Howard JM. Pseudomyxoma peritonei: sudden cardiac death complicating postoperative intraperitoneal treatment with 5-fluorouracil. Digest Surg 1999; 16: 80-82.
7. Burger AJ, Mannino S. 5-Fluorouracil-induced vasospasm. Am Heart J 1987; 114: 433-36.
8. Lieutaud T, Brain E, Colgran-Toledano D, Vincent F, Cvitkovic E, Leclercq B, et al. 5-Fluorouracil cardiotoxicity: a unique mechanism for ischaemic cardiopathy and cardiac failure? Eur J Cancer 1996; 32: 368-69.
9. Mariani G, Giaccon G, Mastore M. Acute severe coronary spasm associated with initial first dose of 5-fluorouracil chemotherapy. Ital Heart J 2003; 4: 568-70.
10. Shoemaker LK, Arora U, Rocha Lima CM. 5-Fluorouracil-induced coronary vasospasm. Cancer Control 2004; 11: 46-49.
11. Lei JT, Holley KE, Titus JL. New histochemical method for morphological diagnosis of early stages of myocardial ischemia. Mayo Clin Proc 1971; 46: 319-317.
12. Regan TJ, Wu CF, Weisse AB, Moschos GB, Ahmed SS, Lyons MM. Acute myocardial infarction in toxic cardiomyopathy without coronary obstruction. Circulation 1975; 51: 453-61.
13. Durak I, Karaayvaz M, Kavutcu M, Cimen MY, Kacmaz M, Buyukkocak S, et al. Reduced antioxidant defense capacity in myocardial tissue from guinea pigs treated with 5-fluorouracil. J Toxicol Environ Health 2000; 59: 585-89.
14. Kuropkat C, Griem K, Clark J, Rodriguez ER, Hutchinson J, Taylor SJ. Severe cardiotoxicity during 5-fluorouracil chemotherapy: a case and literature report. Am J Clin Oncol 1999; 22: 466-70.
15. Movsesian MA. Beta-adrenergic receptor agonists and cyclic nucleotide phosphodiesterase inhibitors: shifting the focus from isotropy to cyclic adenosine monophosphate. J Am Coll Cardiol 1999; 34: 318-24.
16. Teiger E, Dam TV, Richard L, Wisnewsky C, Tea BS, Gaboury L, et al. Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest 1996; 97: 2891-97.
17. Olivetti G, Abbi R, Quain F, Kajstura J, Cheng W, Nitahara JA, et al. Apoptosis in the failing human heart. N Engl J Med 1997; 336: 1131-41.
18. Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M, Fontaine G. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 1996; 335: 1190-96.
19. Brömme HJ, Holtz J. Apoptosis in the heart: when and why? Mol Cell Biochem 1996; 163/164: 261-275.
20. Labianca R, Beretta G, Clerici M, Fraschini P, Luporini G. Cardiac toxicity of 5-fluorouracil: a study on 1083 patients. Tumori 1982; 68: 505-10.
21. Cwikiel M, Zhang B, Eskilsson J, Wieslander JB, Albertsson M. The influence of 5-fluorouracil on the endothelium in small arteries. An electron microscopic study in rabbits. Scan Microsc 1995; 9: 561-76.
22. Kinhult S, Albertsson M, Eskilsson J, Cwikiel M. Antithrombotic treatment in protection against thrombogenic effects of 5-fluorouracil on vascular endothelium: a scanning microscopy evaluation. Scanning 2001; 23: 1-8.